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Reduction of the intake of food and water is responsible for 
reduction of litter growth when dams are treated with a 
progesterone antagonist 
BY P. V A N  DER SCHOOT', T. A. ZEEGERS', F. A. J. MUSKIET',  
A N D  E. J. SLAPPENDEL'  
'Department of Endocrinology and Reproduction, Faculty of Medicine, Erasmus University, 
Rotterdam. 'Central Laboratory for  Clinical Chemistry, Academic Hospital, State University, 
Groningen, The Netherlands 
(Received I May 1990 - Accepted 23 November 1990) 
Treatment of lactating rats with the anti-progestin Mifepristone or Onapristone adversely affects growth 
of their litters. The present studies aimed to elucidate the underlying mechanism. The treatment did not 
interfere with the behavioural interactions between mothers and pups, which are required for normal 
litter growth. Treatment with the antagonists had a stimulatory action on ovarian oestrogen production. 
However, ovarian hormones did not play a role in litter growth impairment, as this also occurred with 
lactating ovariectomized rats. Treatment with anti-progestins did not affect the concentrations of the 
macronutrients in milk (protein, lactose and lipid), nor did it change the fatty acid composition of lipid. 
Reduced litter growth was not related to a possible direct effect of exposure of the suckling young to the 
drugs via the milk. Direct injections into them unequivocally affected adrenal gland and testicular 
development, but did not affect their body-weight development. Milk secretion, as measured by the milk 
weight accumulating during 6 or 24 h following sudden removal of litters in advanced lactation, was not 
impaired by the treatments. However, the ingestion of food and water by dams treated with Mifepristone 
was significantly below that of control animals. It is concluded that litter growth impairment during 
treatment of lactating rats with anti-progestin results from the reduction of the intake of food and water 
by the mother. 
Anti-progestin: Mifepristone: Onapristone: Litter growth: Lactation: Rat 
The anti-progestin Mifepristone affects corpus luteum function in rats. Such action can be 
demonstrated in both normal and lactating rats. In the latter, suckling provides an almost 
continuous stimulation of luteal function through its stimulatory effect on pituitary release 
of prolactin (van der Schoot et al. 1987, 1989, 1990). During our studies, daily treatment 
of lactating rats with Mifepristone reduced litter growth by about 25% from day 10 of 
lactation. This was unlikely to result from reduced suckling time or reduced numbers of 
milk ejections elicited by sucking pups (van der Schoot et al. 1989). 
Mifepristone induces alterations in ovarian activity. These could be responsible for 
impaired litter growth as ovulations occur despite suckling. Oestrogen secretion associated 
with imminent ovulation has been postulated to impair lactational performance, as 
established by impaired litter weight increase (Zeilmaker, 1969). Oestrogens are known to 
alter production and disposal of plasma lipoproteins, as evidenced by increase of plasma 
very-low-density lipoproteins (Knopp et a[. 198 1). Oestrogen administration may directly 
affect the mammary glands to suppress milk secretion (Bruce & Ramirez, 1970; Tucker, 
1988). Thus, oestrogens may alter qualitative and quantitative aspects of the milk lipid 
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fraction. This fraction represents, at least in the human species, the main source of energy 
(Blanc, 1981) and contains constitutive elements for the newborn (Clandinin et al. 1982; 
Koletzko et al. 1989). Reduced litter growth when dams are treated with Mifepristone 
could thus represent the effect of enhanced endogenous oestrogen production resulting 
from this treatment, and a further analysis could reveal the way by which oestrogens act 
to show this effect. 
However, besides effects of oestrogens on milk production or composition, other factors 
could underlie the reduced litter growth. The treatment might affect the suckling pups 
through ingestion of the drug or its metabolites via the milk. Besides anti-progestagenic 
activity, Mifepristone has been shown to produce anti-glucocorticoid action. The known 
importance of adrenocorticosteroids for successful lactation (e.g. van der Schoot & de 
Greef, 1986) points at another potential mechanism of action of Mifepristone during 
lactation. 
The present experiments were performed in an attempt to elucidate the underlying 
mechanism of impaired litter growth during treatment of lactating rats with Mifepristone. 
MATERIALS A N D  METHODS 
Rats 
The experiments were carried out with 2-3-month-old rats obtained from the Wistar 
breeding colony of TNO-Rijswijk (Rijswijk, The Netherlands). The animals were housed 
in a regimen of 14 h light-I0 h darkness (lights on 05.00-19.00 hours) and fed ad lib. with 
a commercial diet and tap water. Females were impregnated by males of proven fertility. 
Animals were included in the experiments when the litter size was nine or more. On day 2 
of lactation (day 1 being the day of parturition) litters were adjusted to ten. 
Treatment 
Rats were treated with the progesterone antagonist Mifepristone (RU-38.486; Roussel- 
Uclaf, France) or Onapristone (ZK-98.299 ; Schering, Berlin, Germany). Microcrystalline 
suspensions containing 20 mg in 1 ml olive oil were prepared. Lactating rats received 0.1 ml 
(2 mg antagonist) subcutaneously/d from the day of parturition. Newborn rats received 
0.05 ml (1 mg antagonist) subcutaneously every other day from day 4 (day of birth being 
day 1). 
Experiments 
Anti-progestins, post-partum ovariectomy, and litter-weight changes. The ovarian con- 
tribution to impaired litter growth was examined by studying lactating rats which were 
ovariectomized on the day after parturition. Ovariectomy has no profound effect on 
lactation beyond the period immediately after surgery (van der Schoot & de Greef, 1983). 
Ovariectomy was performed under light diethyl ether anaesthesia on the day after 
parturition. Daily injections with Mifepristone, Onapristone or olive oil started immediately 
after surgery. An additional group of rats was treated daily with oestradiol- 17P-benzoate 
(OB; 0.01 mg/d in 0.1 ml olive oil). Litter growth was recorded by weighing every other 
day. After weighing, each litter was placed with a female of another experimental group in 
order to get balanced results of weight increases per 2 d from all litters with all four types 
of lactating dams. 
The possible involvement of Mifepristone ingestion by suckling pups in impaired litter 
growth. Newborn litters ( n  6) were rearranged to ten-pup litters of only females or males. 
In each litter, half the animals were subcutaneously injected every other day, from day 4 
until day 18 of lactation, with 1 mg Mifepristone in 0.05 ml oil, or with oil only. The 
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amount of Mifepristone was chosen to ensure that pups obtained more than could ever 
have been ingested via milk. 
The effect of these injections on pup growth was evaluated by weighing the two treatment 
groups per litter separately every other day. On day 20, five male and female pups were 
killed and examined to see whether the treatment with Mifepristone had caused bodily 
effects such as changes in the weights of adrenal and pituitary glands and testes. 
Treatment with Mifepristone, Onapristone, or OB and milk composition. Possible effects 
of treatment with Mifepristone or Onapristone on milk composition were examined in rats 
with ovaries in situ, whereas the possible effects of treatment with OB were examined in rats 
ovariectomized on the day after parturition. After 21 d of successful lactation, litters were 
removed from their mothers. After 24 h, milk was expressed through the nipples from the 
engorged mammary glands: 1-23 ml was easily obtained from the rats treated with 
Mifepristone or Onapristone which allowed for analysis of samples from individual rats. 
However, expression of milk from rats which had been treated with OB occurred only with 
great difficulty and individual animals gave no more than 0.24.8 ml from their twelve 
nipples. Milk expressed from two to three rats was pooled to give samples of 1.5 ml or 
more, the amount required for proper milk composition analysis. Samples were stored at 
- 20” for later analysis. Analysis comprised determination of the concentrations (g/l) of 
protein (Lowry et al., 1951), lactose (Jensen et al. 1986), and fatty acids (van der Steege 
et al. 1987). Triacylglycerol concentration was calculated as one-third of the sum of the 
concentrations of individual fatty acids, taking molecular weights into account. Results of 
fatty acid analysis are presented as mean values in treatment groups. 
Mifepristone, milk secretion, and intake of food and water. The effect of treatment with 
Mifepristone or OB on milk secretion in advanced lactation was estimated in two ways. 
First, an estimate of secreted amount of milk weight was made by measuring the weight of 
the left inguinal mammary gland pad at weaning on day 22 of lactation or 24 h after 
weaning. Second, milk secretion was estimated on day 18 of lactation in two further groups 
of four rats each. Litters were removed from their mothers on  day 18 a t  zero time and the 
weights of the dams and litters were recorded. After 6 h these weights were recorded again 
and the litters were reunited with their own mothers. Weighing was repeated 1 and 2 h after 
reunion. 
Consumption of food and water by lactating dams was estimated by daily weighing of 
the available amounts of pelleted food and the water bottles between days 10 and 17 of 
lactation. This rather crude approach seemed appropriate, provided that care was taken to 
use bottles which did not lose water via ways other than drinking, and that only large food 
pellets were provided. Additionally, weights of dams and litters were recorded daily to 
allow for the calculation of ‘food efficiency’, i.e. the ratio between daily intake 
(food + water; g) and the daily increase (g) of the weight of litter + dam. 
Statistics 
Results were analysed with Student’s t test, or parametric one- or two-way analysis of 
variance followed by Tukey’s honestly significant difference test (Kirk, 1968). P = 0.05 was 
adopted as the upper limit for statistical significance of observed differences. 
R E S U L T S  
Anti-progestins, post-partum ovariectomy, and litter weight changes 
The results are presented in Tables 1 and 2. Treatment of lactating ovariectomized rats with 
Mifepristone or  Onapristone reduced litter weight gain. Between days 2 and 22 of lactation, 
the weight increment of ten-pup litters with unoperated or control ovariectomized dams 
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Table 1. Growth of ten-pup litters with intact and ovariectomized* rats treated with 
Mifepristone or Onapristone (2 mgld) ,  oestradiol-17j3-benzoate (0.01 m g l d )  or oil solvent 
(Mean values with their standard errors for six litters) 
(0.1 m o t  
Litter wt increase (g) 
between days 2 and 22 
Treatment Mean SE 
Intact +oil 329 I0 
Ovariectomy 
+oil 336 18 
+ Mifepristone 2971 17 
+ Onapristone 2681 11 
+ Oestradiol benzoate losp 9 
._ 
____ 
* Ovariectomy on day after parturition. 
t For details of treatments, see p. 18. 
$ One-way ANOVA : weight increase was significantly less than that for intact +oil and ovariectomy + oil 
5 One-way ANOVA: weight increase was significantly less than that of all other groups. 
groups. 
Table 2. EfSect of treatment with Mifepristone, Onapristone, oestradiol-I 7j3-benzoate (OB) 
or oil solvent on body and organ weights of intact and ovuriectomized ( O V m  lactating ruts 
at the end of lactation* 
(Mean values with their standard errors for six rats per group unless otherwise indicated) 
_ _  ~- 
Inguinal mammary gland (mg)t 
Adrenal 
Body-wt (g) gland (mg) Uterus (mg) At weaning 24 h later 
Treatment Mean SE Mean SE Mean SE Mean SE Mean SE 
~~ 
Intact t o i l  solvent 268 8 43 2 400 41 6053 656 11216 887 
OVX 
+Oil solvent 271 8 46 1 106 2 6532 544 15260 1998 
+ Mifepristone 280 2 46 3 119 6 7065 641 12479 1082 
+ Onapristone 272 10 43 2 108 4 5631 718 11631 663 
+ OB 244 6 46 3 739 43 5019 227 10429 345 
1 NS Q II /I 
NS, not significant. 
* For details of treatments, see p. 18. 
t Mean values for three rats per treatment group. 
1 One-way ANOVA: OB-treated group was different from all other groups. 
5 One-way ANOVA: OVX groups were different from intact group; OVX +OB group was different from three 
11 Two-way ANOVA: no difference between groups (F4,10 2.5; P > 0.05) but difference between 0 and 24 h 
other OVX groups. 
(Fl,lo 38; P < 0.001). 
was significantly higher than those of litters with dams treated with either anti-progestin. 
Impairment of litter weight gain was in the same order for both compounds. Impairment 
was much less than that with dams treated with OB. The treatment with the anti-progestins 
did not affect the body-weights of the ovariectomized dams. The post-ovariectomy decrease 
in weight of the uterus was not altered under the influence of the compounds. OB treatment 
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resulted in lower body-weight and increased uterine weight at  the end of lactation. The 
dams’ adrenal gland weights, or  the weights of the inguinal mammary gland pads at the end 
of lactation or 24 h after weaning were similar in all five groups (Table 2). 
The possible involvement of Mifepristone ingestion by suckling pups in impaired litter 
growth 
Injections of Mifepristone into newborn male and female pups did not affect pup growth : 
between days 10 and 20 of lactation, male and female pups grew equally well, regardless 
of whether they were injected regularly with oil (increase 108 (SE 3) g/five pups per 10 d ;  
sexes combined) or with Mifepristone in oil (103 (SE 3) g/five pups per 10 days; paired 
t test: P = 0.16). 
At autopsy on day 20,2 d after the last injections of either Mifepristone or oil, there were 
no obvious external bodily signs of the exposure of male or female pups to Mifepristone. 
However, the weights of adrenal glands (both sexes) and testes were significantly affected 
(Table 3). 
Trearment with Mifepristone, Onapristone, or OB and milk composition 
The results of the analysis of macronutrients and fatty acid composition of milk are 
presented in Tables 4 and 5 respectively. Neither of the anti-progestins affected 
macronutrient or fatty acid composition. OB did not change macronutrients, but did 
change fatty acid composition. Most remarkable were the changes in the relative amounts 
of mono-unsaturated fatty acids (notably 14: ln-5, 16: ln-7, and 18: ln-7), poly- 
unsaturated fatty acids (PUFA; notably long chain PUFA and 18:2n-6) and medium- 
chain saturated fatty acids (notably 6:0,  12:0, and 14:O). 
Autopsy of the females immediately after milking (Table 6) did not reveal effects of anti- 
progestin on their body-weight, mammary gland weight, adrenal gland weight or uterine 
weight. In accordance with earlier observations, ovarian weight in Mifepristone-treated 
rats had increased due to one or more ovulations from about day 13 of lactation. 
Mifepristone, milk secretion and intake of food and water 
The results of the first estimate of milk secretion are presented in Tables 2 and 6. The left 
mammary gland pads in intact rats, 24 h after litter removal, were of equal weight in all 
treatment groups (Table 6). In the experiment with ovariectomized rats, mammary gland 
pad weights were not significantly different between the five groups at either zero time or 
after 24 h, but the difference between 0 and 24 h was highly significant throughout (Table 
2). Some reservation might arise in view of the low number of observations. However, the 
results in Table 2 add to those in Table 6 and offer a similar result in this respect. 
On the assumption that the left inguinal gland pad represents one-quarter of the total 
amount of glandular tissue it is estimated that in the order of 4 x 6 = 24 g milk had 
accumulated over the last 24 h in all groups. 
Results of litter weight gain and dams’ intake of food and water between days 10 and 17 
of lactation are presented in Table 7. Treatment with Mifepristone significantly decreased 
litter weight gain and intake of both food and water through this period of lactation. There 
was a highly significant correlation between litter growth and the daily intake of food and 
water by the respective mothers (correlation coefficient 0.86; P = 0.001). The intake of food 
and water:litter weight increase ratio appeared identical in the two groups. Daily intake of 
food and water were also highly correlated (correlation coefficient 089; P = 0.0001). 
Results of the estimation of milk secretion following the second protocol are presented 
in Table 8. Separation of mothers and their litters for 6 h on day 17 resulted in appreciable 
accumulation of milk. During the first hour after reunion, litters in both groups showed 
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Table 3. Efect of injections of Mifepristone in infancy ( I  mg in 0.05 ml oil per 2 d from 
day 4), or oil only, on body and organ weights in developing male and female rats? 
(Mean values with their standard errors for five rats per group; autopsy on day 20 after last injection 
on day 18) 
___ 
H ypophysis 
Body-wt (g) Testis (mg) Uterus (mg) Adrenal (mg) (mg) 
Treatment Mean SE Mean SE Mean SE Mean SE Mean SE 
Females 
Oil 37.6 0.6 
Mifepristone 38.2 0.5 
24 1 5.6 0 4  2.6 0.2 
22 I 4.0* 0 3  2.3 0.3 
Males 
Oil 39.4 1.0 7s 4 6.1 0.2 2.3 0.1 
Mifepristone 39.6 0 7  45* 2 3.8* 0.3 2.1 0.1 
Mean values were significantly different from corresponding oil group (Student’s t-test: *P i 001). 
t For details of treatments, see p. 18. 
Table 4. Effect of the daily treatment of lactating rats with progesterone antagonists or 
oestradiol-17/3-benzoate (OB) on macronutrient composition of their milk* 
(Mean values with their standard errors) 
Total 
Protein (g/l) Lactose (g/l) triacylglycerolst (g/ 1) 
Treatment Mean SE Mean SE Mean SE 
Oil 97 5 24 2 63 3 
Mifepristone 104 4 22 1 67 5 
Onapristone 94 5 18 2 76 5 
OB 99 6 19 2 84 6 
ANOVA 
F (df 3) 0.8 2.0 2.2 
P 0.49 0.14 0.12 
._ 
* For details of treatments, see pp. 18-19. 
t Details of fatty acid composition are presented in Table 5 .  
considerable weight increase, and mothers showed a weight decrease accordingly. During 
the second hour of reunion, neither the litters nor their mothers showed a further weight 
change. Results in the two groups were not statistically significantly different. 
D I S C U S S I O N  
The present experiments confirm the earlier observations that treatment of lactating rats 
with Mifepristone interferes with normal litter weight development during the second half 
of the lactation period. Reduced litter weight increase does not seem to result from reduced 
time that dams spend with them or with the ease by which suckling evokes milk ejections 
(Lincoln et al. 1973; van der Schoot et af. 1989). The experiments of the present study were 
designed to elucidate the underlying mechanism. 
Decreased litter growth was observed during treatment with both Mifepristone and 
Onapristone, two potent anti-gestagenic compounds (Neef et al. 1984; Philibert, 1984). The 
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Table 5. Fatty acid composition (mol/100 mol total fatty acids) of rut milk after treatment 
of lactating ruts for  3 weeks with Mifepristone, Onapristone, oestradiol-I 7p benzoate (OB) 
or oil7 
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0 3  0.5 
0.7 0.9 
1.1 1.5* 
* Mean values for OB group were significantly different from those of all other groups (P < 0.05). 
t For details of treatments, see pp. 18-19. 
MCSAFA, 6 :  0-14:O; SAFA, saturated fatty acids; LCSAFA, > C,, : o  MUFA, mono-unsaturated fatty acids; 
Sn-6, sum of n -6 fatty acids; PUFA, polyunsaturated fatty acids; Sn- 3 > C,,, sum of n-3 fatty acids beyond 
chain length C,,; Sn - 6 > C,,, sum of n - 6 fatty acids beyond chain length C,,; LCPUFA, sum of n - 3 + n - 6 
fatty acids beyond chain length C20. 
second drug has been reported to show much reduced anti-glucocorticoid activity 
compared with Mifepristone (Neef et a/. 1984). Neither compound affected adrenal gland 
weight throughout this study. It is concluded that anti-glucocorticoid action of the 
compounds is unlikely to play a role in suppression of litter weight gain. 
Both compounds interfere with the suppression, through suckling, of pre-ovulatory 
follicular development after day 10 of lactation (van der Schoot et ul. 1989). Interference 
with the suppressed follicular development, and thus oestrogen production, was judged an 
obvious candidate for explaining impaired litter growth (Zeilmaker, 1969). Indeed, 
injections of OB markedly interfered with litter growth, but the quantities used in the 
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Table 6. Effect of treatment with Mifepristone or Onapristone on body and organ weights 
at the end of lactation (intact rats)? 




Adrenal a t  24 h after 
Body-wt (g) gland (mg) Ovaries (mg) Uterus (mg) weaning (mg) 
Treatment Mean SE Mean SE Mean SE Mean SE Mean SE 
Oil (n 5 )  272 12 35 1 65 4 308 14 9028 614 
Mifepristone (n 8) 269 9 33 1 94 5 350 19 9437 770 
Onapristone (n  7) 268 7 34 1 63 3 305 20 9101 476 * NS NS NS NS 
* Mean value for group treated with Mifepristone was significantly different from those of the other groups 
t For details of treatments, see p. 18. 
(ANOVA, one-way): P < 0.01 ; NS, not significant. 
Table 7. Effect of treating dams with 2 mg Mifepristoneld or with oil on litter growth and 
on the estimated daily intake of food and water between days I0 and 17 of lactation? 
(Mean values with their standard errors for four rats) 
- -  - 
Daily intake of dams Daily litter 
Food + wt gain 
Water (ml) water (8) (g/24 h) Quotient$ 




Controls 61 2 77 5 138 4 19 2 7 2  0 1  
+ Mifepristone 53* 1 67* 5 120* 3 16* 1 7 2  0.1 
* Mean values significantly different from those of the control group (paired t-test, P < 0 01) 
t For details of treatments, see pp 18-19 
1 Quotient of the daily amounts of food and water taken by the mother and the daily weight gain of 
litter +mother 
present study lead to plasma oestradiol levels which are well above those encountered in the 
normal pre-ovulatory state (Tapper et al. 1974). The effect of both anti-progestins on litter 
growth was similar in lactating ovariectomized rats to that in lactating intact rats. It is, 
therefore, concluded that the ovaries do not play a role in the mechanism of litter growth 
impairment. 
The large amount of Mifepristone injected into their mothers might give rise to effects 
in pups through the passage of the drug into the milk. No effort was made to examine 
concentrations of Mifepristone in milk. Examination of the effects of large amounts of 
Mifepristone, directly injected into suckling pups, seemed more appropriate. Newborn 
male and female rats showed no obvious adverse effects of such treatment with regard to 
body growth or external bodily features. After day 10 of lactation no effect on pup growth 
was observed. The period beyond day 10 represents the period of litter growth disturbance 
in mothers treated with the compound. Effects of Mifepristone on organ weights (testes and 
adrenal glands) on day 18 were considered proof of the bioavailability of subcutaneously 
injected Mifepristone in the newborn. The injected amounts of Mifepristone were far in 
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Table 8. EfSect of treatment with Mifepristone or oil on the mean weight changes of lactating 
dams and their litters during 6 h of separation on day 18 of lactation and thefirst and second 
hour after their reunion.* 
(Mean values with their standard errors for four rats) 
Wt changes (g) during: 
1st hour 2nd hour 
6 h of separation after reunion after reunion 
Mean SE Mean SE Mean SE 
Dams 
Control 9-0 2.1 - 13.8 2.6 2.5 1.7 
Mifepristone 4.3 3.8 - 13.8 1.9 - 0.3 1.2 
Control - 3.8 0.2 12.5 1.6 0.0 0.1 
Mifepristone -3.0 0.0 11.5 1.6 0.5 0.4 
Litters 
*For details of treatments, see p. 18. 
excess of those which could possibly have been ingested via the milk. Direct effects of 
Mifepristone on suckling pups were, thus, unlikely to be the source of disturbed litter 
growth. 
Litter growth is, obviously, critically dependent on milk secretion. Evaluation of milk 
secretion is difficult, but various indirect methods for estimating milk secretion are easily 
available. Litter removal in an advanced stage of lactation will result in engorgement of the 
mammary glands. The weight of accumulated milk can be estimated by measuring weight 
increases of the mammary glands. A different approach is the examination of litter weight 
increase after a temporary separation of litters from their mothers. On reunion, pups 
immediately grasp to the nipples. Milk becomes available rapidly and in large amounts 
both through direct expression (‘tap reflex’) and in response to oxytocin as revealed by 
specific behaviours of the sucking pups (Lincoln et al. 1973). Results of examination of 
both indices of milk secretion did not indicate that Mifepristone or Onapristone interfered 
with milk secretion. Moreover, the measurement of macronutrient and fatty acid 
composition of milk did not reveal effects of treatment with Mifepristone or Onapristone. 
After the previous experiments had failed to elucidate the mechanism of litter growth 
disturbance, the final experiment aimed to examine litter growth in relation to intake of 
food and water by lactating rats. Until around day 18 of lactation litter weight increase is 
totally dependent on milk ingestion : direct observation of litters with their mothers never 
revealed attempts by pups to take solid food or water. Litter weight increase thus totally 
depends on : (a) amounts of food and water taken up by their mother and (b) efficiency by 
which ingested food is transformed into milk in the mammary glands. It appeared that 
dams treated with Mifepristone ingested significantly less food and water than controls. 
The mother’s intake of food and water: litter weight increase ratio appeared identical in the 
two groups of rats. The total intake of food and water was highly correlated with litter 
growth. These observations lead to the possible explanation of disturbed litter growth, 
namely interference through Mifepristone with the usual intake of food and water required 
for normal litter growth. 
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